ES554166A0 - Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos. - Google Patents

Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Info

Publication number
ES554166A0
ES554166A0 ES554166A ES554166A ES554166A0 ES 554166 A0 ES554166 A0 ES 554166A0 ES 554166 A ES554166 A ES 554166A ES 554166 A ES554166 A ES 554166A ES 554166 A0 ES554166 A0 ES 554166A0
Authority
ES
Spain
Prior art keywords
pharmaces
discharge
manufacture method
distributor device
controlled speed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554166A
Other languages
English (en)
Other versions
ES8801114A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ES554166A0 publication Critical patent/ES554166A0/es
Publication of ES8801114A1 publication Critical patent/ES8801114A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
ES554166A 1985-04-22 1986-04-18 Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos. Expired ES8801114A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/725,839 US4624847A (en) 1985-04-22 1985-04-22 Drug delivery device for programmed delivery of beneficial drug

Publications (2)

Publication Number Publication Date
ES554166A0 true ES554166A0 (es) 1987-12-16
ES8801114A1 ES8801114A1 (es) 1987-12-16

Family

ID=24916166

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554166A Expired ES8801114A1 (es) 1985-04-22 1986-04-18 Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.

Country Status (9)

Country Link
US (1) US4624847A (es)
JP (1) JPS61280418A (es)
CA (1) CA1267089A (es)
CH (1) CH667589A5 (es)
DE (1) DE3613454A1 (es)
ES (1) ES8801114A1 (es)
FR (1) FR2580501B1 (es)
GB (1) GB2173704B (es)
IT (2) IT1188097B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764380A (en) * 1982-03-22 1988-08-16 Alza Corporation Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills
EP0277092B1 (de) * 1987-01-14 1992-01-29 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
JPS63250488A (ja) * 1987-04-06 1988-10-18 Murata Mfg Co Ltd めつき処理方法
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4957494A (en) * 1987-06-25 1990-09-18 Alza Corporation Multi-layer delivery system
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5499979A (en) * 1987-06-25 1996-03-19 Alza Corporation Delivery system comprising kinetic forces
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
US5803712A (en) 1988-05-17 1998-09-08 Patient Solutions, Inc. Method of measuring an occlusion in an infusion device with disposable elements
US5074756A (en) 1988-05-17 1991-12-24 Patient Solutions, Inc. Infusion device with disposable elements
US5246347A (en) 1988-05-17 1993-09-21 Patients Solutions, Inc. Infusion device with disposable elements
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
DD295760A5 (de) * 1989-01-31 1991-11-14 Martin-Luther-Universitaet Halle Wittenberg,De Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
US5100392A (en) * 1989-12-08 1992-03-31 Biosynthesis, Inc. Implantable device for administration of drugs or other liquid solutions
EP0507933B1 (en) * 1990-10-31 1996-05-22 Baxter International Inc. Close vascularization implant material
US5713888A (en) * 1990-10-31 1998-02-03 Baxter International, Inc. Tissue implant systems
US5733336A (en) * 1990-10-31 1998-03-31 Baxter International, Inc. Ported tissue implant systems and methods of using same
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
US5801141A (en) * 1991-06-24 1998-09-01 American Cyanamid Company Implant compositions containing a biologically active protein, peptide or polypeptide
US5226902A (en) * 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
WO1995008289A2 (en) 1993-09-16 1995-03-30 Scimed Life Systems, Inc. Percutaneous repair of cardiovascular anomalies and repair compositions
CA2148354A1 (en) * 1993-09-24 1995-03-30 Laura A. Martinson Methods for enhancing vascularization of implant devices
US5792106A (en) * 1993-12-02 1998-08-11 Scimed Life Systems, Inc. In situ stent forming catheter
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US6156305A (en) * 1994-07-08 2000-12-05 Baxter International Inc. Implanted tumor cells for the prevention and treatment of cancer
US5733270A (en) * 1995-06-07 1998-03-31 Baxter International Inc. Method and device for precise release of an antimicrobial agent
US5869078A (en) * 1996-04-25 1999-02-09 Medtronic Inc. Implantable variable permeability drug infusion techniques
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
WO1999018797A1 (en) 1997-10-09 1999-04-22 Emory University Method and devices for transdermal delivery of lithium
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
EP1967185A1 (en) * 1999-12-23 2008-09-10 Pfizer Products Inc. Hydrogel-driven drug dosage form
WO2001047498A2 (en) 1999-12-23 2001-07-05 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
AU2141202A (en) 2000-12-05 2002-06-18 Alexander Macgregor Hydrostatic delivery system for controlled delivery of agent
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
MXPA04012976A (es) * 2002-06-17 2005-05-16 Alza Corp Sistema de distribucion osmotica con medio de potencia de empuje de orden cero temprana que comprende un agente osmotico disperso en el vehiculo fluido.
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
WO2005051322A2 (en) * 2003-11-25 2005-06-09 Sb Pharmco Puerto Rico Inc. Controlled release pharmaceutical formulations comprising carvedilol, free based and its salts
US20070009573A1 (en) * 2005-07-07 2007-01-11 L N K International Method of forming immediate release dosage form
CA2657435A1 (en) 2006-07-10 2008-07-03 Medipacs, Inc. Super elastic epoxy hydrogel
WO2009073734A2 (en) 2007-12-03 2009-06-11 Medipacs, Inc. Fluid metering device
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
WO2010118232A1 (en) * 2009-04-09 2010-10-14 Elan Pharma International Limited Controlled-release clozapine compositions
WO2011032011A1 (en) 2009-09-10 2011-03-17 Medipacs, Inc. Low profile actuator and improved method of caregiver controlled administration of therapeutics
US9500186B2 (en) 2010-02-01 2016-11-22 Medipacs, Inc. High surface area polymer actuator with gas mitigating components
WO2012061556A1 (en) 2010-11-03 2012-05-10 Flugen, Inc. Wearable drug delivery device having spring drive and sliding actuation mechanism
HK1206374A1 (en) 2012-03-14 2016-01-08 麦德医像公司 Smart polymer materials with excess reactive molecules
CN105188682A (zh) 2013-01-09 2015-12-23 埃奇蒙特制药有限公司 劳拉西泮的控释制剂
US8999393B1 (en) 2013-01-09 2015-04-07 Edgemont Pharmaceuticals Llc Sustained release formulations of lorazepam

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4203439A (en) * 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4210139A (en) * 1979-01-17 1980-07-01 Alza Corporation Osmotic device with compartment for governing concentration of agent dispensed from device
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device

Also Published As

Publication number Publication date
JPH0428242B2 (es) 1992-05-13
CA1267089A (en) 1990-03-27
DE3613454A1 (de) 1986-10-23
US4624847A (en) 1986-11-25
CH667589A5 (de) 1988-10-31
JPS61280418A (ja) 1986-12-11
IT8653309V0 (it) 1986-04-21
ES8801114A1 (es) 1987-12-16
GB2173704B (en) 1989-08-23
IT8667331A0 (it) 1986-04-21
GB8609218D0 (en) 1986-05-21
FR2580501B1 (fr) 1990-08-10
GB2173704A (en) 1986-10-22
FR2580501A1 (fr) 1986-10-24
IT1188097B (it) 1987-12-30

Similar Documents

Publication Publication Date Title
ES554166A0 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES554167A0 (es) Metodo para la fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES554165A0 (es) Metodo de fabricacion de un nuevo dispositivo distribuidor para la descarga a velocidad controlada de farmacos.
ES556477A0 (es) Metodo de fabricacion de un nuevo sistema distribuidor para la descarga a velocidad controlada de un farmaco beneficioso.
ES556147A0 (es) Metodo de fabricacion de un nuevo sistema para la descarga a velocidad controlada de un farmaco beneficioso.
ES556375A0 (es) Metodo de fabricacion de un nuevo sistema distribuidor para la descarga a velocidad controlada de farmacos beneficiosos
ES545366A0 (es) Metodo para la fabricacion de dispositivos de liberacion a velocidad controlada de agentes beneficiosos.
ES539852A0 (es) Un nuevo procedimiento para la preparacion de nuevos derivados. de carbazolona.
ES521635A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES524446A0 (es) Un procedimiento para la preparacion de nuevos derivados.
ES512661A0 (es) Un metodo para la preparacion de plaquetas estabilizadas.
ES522678A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
ES524447A0 (es) Un procedimiento para la preparacion de nuevos derivados arilfenolicos.
ES517707A0 (es) Un metodo para la fabricacion de envases.
ES513287A0 (es) "un metodo con su aparato correspondiente, para la limpieza de electrodos".
ES530393A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolonas.
ES517296A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES524610A0 (es) Un procedimiento para la preparacion de nuevos derivados de fosfolipidos.
ES521293A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbapenem.
BR8201123A (pt) Bocal de dupla funcao para um sistema de lubrificacao
ES524317A0 (es) Un procedimiento para la preparacion de nuevos derivados de tienopirimidina.
ES517295A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanolamina.
ES523501A0 (es) "un metodo para preparar derivados de 3-metilflavona".
ES514141A0 (es) Un procedimiento para la produccion de un nuevo antibiotico.
ES522389A0 (es) Un procedimiento para la preparacion de nuevos derivados de penem-2-tiosustituidos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519